← Oncology Approval Tracker

FDA DECISION ·

Blincyto

blinatumomab · Amgen

FDA approvalNew or expanded indicationAcute lymphoblastic leukemia
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Adults and children aged 1 month and older with CD19-positive, Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia during consolidation of multiphase chemotherapy.

LAMPGEN ANALYSIS

Why it matters

The indication moves blinatumomab into consolidation beyond its earlier residual disease and relapsed disease settings.

What research teams should watch

Define how inpatient starts, pump changes and home infusion handoffs are recorded across pediatric and adult services.

PRIMARY RECORDS

Sources